Position in NVS
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$1,518,615
-$13,008 QoQ
Shares Held
9,690
-3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#503
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STOCK YARDS BANK & TRUST CO holds $201,735,695 across 11 Drug Manufacturers - General names. NVS ranks #9 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
115,822 | $138,920,392 | |
| 2 | JNJ |
Johnson & Johnson
|
94,450 | $23,987,466 | |
| 3 | ABBV |
AbbVie Inc.
|
57,998 | $14,594,616 | |
| 4 | MRK |
Merck & Co., Inc.
|
79,544 | $10,221,404 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
73,085 | $4,211,157 | |
| 6 | AMGN |
Amgen Inc
|
10,845 | $3,927,191 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
14,626 | $1,847,847 | |
| 8 | PFE |
Pfizer Inc
|
65,446 | $1,575,938 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,518,615 | 9,690 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $1,531,623 | 10,027 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,550,071 | 11,243 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,457,831 | 11,368 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,408,676 | 11,641 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,304,983 | 11,706 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,234,085 | 12,682 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,218,389 | 19,287 | Shares | Sole | 2024-11-22 | |
| 2024-06-30 | $2,179,022 | 20,468 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,989,348 | 20,566 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,074,125 | 20,542 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,272,089 | 22,306 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,279,354 | 22,588 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $2,146,912 | 23,336 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,112,778 | 23,289 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,822,263 | 23,974 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,934,637 | 22,887 | Shares | Sole | 2022-08-24 | |
| 2022-03-31 | $236,135 | 2,691 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $235,381 | 2,691 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $223,095 | 2,728 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $340,142 | 3,728 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $252,251 | 2,951 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $297,076 | 3,146 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $295,315 | 3,396 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $383,945 | 4,396 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $385,205 | 4,672 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||